Medical management of nephrolithiasis.
D000493:Allopurinol / Q000627:therapeutic use; D000553:Ambulatory Care; D001581:Benzothiadiazines; D002118:Calcium / Q000652:urine; D002129:Calcium Oxalate / Q000652:urine; D002136:Calcium, Dietary / Q000008:administration & dosage; D002411:Cation Exchange Resins / Q000627:therapeutic use; D002482:Cellulose / Q000031:analogs & derivatives / Q000627:therapeutic use; D002951:Citrates / Q000627:therapeutic use / Q000652:urine; D019343:Citric Acid; D002986:Clinical Trials as Topic; D004232:Diuretics; D005440:Fluid Therapy; D006801:Humans; D007669:Kidney Calculi / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D010710:Phosphates / Q000627:therapeutic use; D012008:Recurrence; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014527:Uric Acid / Q000652:urine
D001581:Benzothiadiazines; D002136:Calcium, Dietary; D002411:Cation Exchange Resins; D002951:Citrates; D004232:Diuretics; D010710:Phosphates; D049993:Sodium Chloride Symporter Inhibitors; D002129:Calcium Oxalate; D014527:Uric Acid; D019343:Citric Acid; D000493:Allopurinol; D002482:Cellulose; C008881:phosphocellulose; D002118:Calcium